Case Study:
Read "Patent Games: Plavix". Answer the following questions:
Question 1. Why did Bristol-Myers Squibb and Sanofi-Aventis seek a settlement rather than let the patent infringement case go to trial?
Question 2. Should Bristol-Myers Squibb and Sanofi-Aventis have attempted to pay Apotex to prevent it from launching a generic version of Plavix?
Question 3. Was Sherman's strategy that of a shrewd business executive? Did Sherman act ethically in his strategy?
Question 4. Should the FTC and the state attorneys general have rejected the agreements?
Question 5. Did Bristol-Myers Squibb likely violate the deferred prosecution agreement?
References:
Baron, D. P. (2010). Business and its environment (6th ed.). Upper Saddle River, NJ: Prentice Hall.